Skip to content
Disclosery

13F-HR filed by SUPERSTRING CAPITAL MANAGEMENT LP

SUPERSTRING CAPITAL MANAGEMENT LP filed this 13F-HR for the quarter ended 2024-12-31, filed 2025-02-14, with 39 holding rows worth $115,483,430.

Accession
0001931118-25-000002
Filer
CIK 1931118
Filed
2025-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2024

A holdings report, 39 entries on the cover page, a total value of $115,483,430 stated on the cover page (in dollars after the unit check, H1), rows summing to $115,483,430 with VALUE read as dollars as filed, 13F file number 028-23866. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ORIC PHARMACEUTICALS INC68622P109COM1,580,745$12,756,612dollars as filed
TERNS PHARMACEUTICALS INC COM880881107Stock2,020,562$11,193,913dollars as filed
ZAI LAB LTD ADR98887Q104ADR403,630$10,571,070dollars as filed
NOVOCURE LTDG6674U108ORD SHS286,970$8,551,706dollars as filed
BRIDGEBIO PHARMA INC10806X102COM262,141$7,193,149dollars as filed
COGENT BIOSCIENCES INC19240Q201COM910,865$7,104,747dollars as filed
CYTOKINETICS INC23282W605COM NEW129,389$6,086,459dollars as filed
STRUCTURE THERAPEUTICS INC COMP86366E106EQUITY216,811$5,879,914dollars as filed
IDEAYA BIOSCIENCES INC COM45166A102Stock227,102$5,836,521dollars as filed
UROGEN PHARMA LTDM96088105COMMON STOCK301,206$3,207,844dollars as filed
SUMMIT THERAPEUTICS INC86627T108COM164,564$2,936,645dollars as filed
Instil Bio Inc45783C200COM NEW148,017$2,825,645dollars as filed
PROTAGONIST THERAPEUTICS74366E102COM68,892$2,659,231dollars as filed
INSMED INC COM PAR $.01457669307Stock35,966$2,483,093dollars as filed
FATE THERAPEUTICS INC31189P102COM1,379,556$2,276,267dollars as filed
LEGEND BIOTECH CORP52490G102SPONSORED ADS69,594$2,264,589dollars as filed
PROTARA THERAPEUTICS INC74365U107COM STK360,000$1,900,800dollars as filed
CABALETTA BIO INC12674W109COMMON STOCK822,293$1,866,605dollars as filed
DYNE THERAPEUTICS INC COM26818M108Stock73,150$1,723,414dollars as filed
ORIC PHARMACEUTICALS INC68622P109COM200,000$1,614,000dollars as filedcall
SAVARA INC805111101COM508,338$1,560,598dollars as filed
TANGO THERAPEUTICS INC87583X109COM474,955$1,467,611dollars as filed
KURA ONCOLOGY INC COM50127T109Stock157,959$1,375,823dollars as filed
INCYTE CORP COM45337C102Stock18,009$1,243,882dollars as filed
BEONE MEDICINES LTD SPONSORED ADS07725L102ADR6,365$1,175,679dollars as filed
VERASTEM INC92337C203COMMON STOCK209,889$1,085,126dollars as filed
89BIO INC282559103COM132,982$1,039,919dollars as filed
ZENAS BIOPHARMA INC COM98937L105Stock111,605$914,045dollars as filed
CAPRICOR THERAPEUTICS INC14070B309COMMON STOCK55,229$762,160dollars as filed
KYVERNA THERAPEUTICS INC501976104COMMON STOCK182,177$681,342dollars as filed
REZOLUTE INC76200L309COMMON STOCK123,184$603,602dollars as filed
CENTURY THERAPEUTICS INC15673T100COM462,963$467,593dollars as filed
ZURA BIO LTDG9TY5A101COMMON STOCK186,943$467,358dollars as filed
EYEPOINT INC COM NEW30233G209Stock49,375$367,844dollars as filed
AXSOME THERAPEUTICS INC. COM05464T104Stock4,268$361,115dollars as filed
MADRIGAL PHARMACEUTICALS INC COM558868105Stock1,129$348,376dollars as filed
LEXEO THERAPEUTICS INC52886X107COMMON STOCK52,616$346,213dollars as filed
CLIMB BIO INC28658R106COMMON STOCK98,160$176,688dollars as filed
LAKESHORE BIOPHARMA CO LTDG9845F208COM30,792$106,232dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001931118-25-000002this filing2025-02-14acceptance time not in the bulk data set